鉴定和描述新型 Chikungunya 病毒聚合酶抑制剂
bioRxiv : the preprint server for biology
|September 26, 2025
概括
研究人员发现了新的小分子抑制剂,用于奇孔古尼亚病毒 (CHIKV) 和相关的α病毒. 这些化合物向病毒nsP4聚合酶,为开发对这些重要的人类病原体急需的抗病毒疗法提供了有希望的途径.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 奇孔古尼亚病毒 (CHIKV) 和其它阿尔法病毒是人类的重要病原体,在全球造成数百万例感染.
- 阿尔法病毒感染表现为关节致病性疾病,具有令人虚弱的关节疼痛,发烧和皮疹,目前缺乏授权的疫苗或抗病毒治疗.
- 现有的疫苗只能用于CHIKV,使其他α病毒和CHIKV感染没有有效的治疗选择.
研究的目的:
- 开发一种高通量选试验,用于识别CHIKV复制的新型小分子抑制剂.
- 发现和描述能够有效抑制阿尔法病毒复制的化学化合物.
- 为开发针对CHIKV和相关alphavirus的新抗病毒疗法奠定基础.
主要方法:
- 一个CHIKV纳米化酶记者病毒被用来建立一个高通量选试验.
- 小分子抑制剂被选为它们抑制病毒复制的能力.
- 对已识别的抑制剂进行了机械特征和耐药性分析,包括in silico对接分析.
主要成果:
- 确定了几种独特的CHIKV复制的小分子抑制剂.
- 发现有两种有前途的抑制剂可向病毒nsP4RNA依赖RNA聚合酶.
- 特定的nsP4突变赋予对抑制剂的耐药性被精确地确定,并预测了在活性部位附近的潜在结合部位.
结论:
- 该研究确定了具有开发CHIKV抑制剂潜力的新化学型.
- 病毒nsP4聚合酶代表了一种可行的分子标来抑制alphavirus.
- 这些发现为开发迫切需要的抗病毒疗法来对抗 chikungunya 病毒和相关的 alpha 病毒提供了基础.
相关概念视频
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


